According to tumoral expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2), breast cancer is classified into four molecular subtypes: luminal A, luminal B, HER-2 type, and triple-negative breast cancer (TNBC). Here, ERBB2 is linked to triple-negative breast carcinoma.